Should You Invest In USG Corporation (USG), SandRidge Energy Inc ( SD) and The Medicines Company (MDCO)?

Posted by admin April 21, 2015 0 Comment 1263 views

New York, NY – GDP INSIDER  –  04/21/2014.

This article discusses three companies: USG Corporation (NYSE:USG), SandRidge Energy Inc.(NYSE:SD) and The Medicines Company (NASDAQ:MDCO)

USG Corporation (NYSE:USG) continued to decline yesterday with the stock losing another 0.95% or $0.25 to close the day at $26.01on active trading volume of 1.85 million shares, compared to its 30 day average trading volume of 1.76 million. USG Corporation has been underperforming the S&P 500 so far this year, with the stock losing 7.07% YTD, compared to the S&P 500 which has gained 2.02% over the same period. With quarterly revenue growth of 4.30% year on year and RSI of 40.75, the stock should still continue to rise and get closer to its one year target estimate of $30.04, making it a hold and potential buy.

Can USG Corporation Maintain Its Upward Trend? Click Here For Free USG Analysis.

SandRidge Energy Inc.(NYSE:SD) started to reverse recent losses with the stock closing up 3.45% or $0.07 to close at $2.10, on light trading volume of 8.607 million compared to its three month average of 15.63 million. SandRidge Energy Inc has not been doing as badly as many companies in the oil and gas drilling and exploration sector with the stock only down 68.89% over the past one year. Until the sector stabilizes and oil begins to stable, the stock is likely to continue its downward trend making it a hold.

Is It Worth Taking A Long Term View On SandRidge Energy Inc? Find Out More From Our Free SD Analysis.

The Medicines Company (NASDAQ:MDCO) continued to fall yesterday with the stock declining 5.64% or $1.64 to finish the day at a closing price of $27.44 with more than 1.898 million shares changing hands compared to its three month average trading volume of 1.32 million. The $1.91 billion market cap pharmaceutical company, which delivers the medicines to the global hospital marketplace, has been doing well over the past six months, with the stock up 27.87%, compared to the S&P 500, which has only gained 10.31% over the same period. With RSI of 42.09 and one year target price estimate of $32.86, the stock should continue to rise, making it a hold for now.

What Does The Future Hold For The Medicines Company? Read Our Free MDCO Investment Analysis To Know More.

About Ultimate Stock Alerts covers NASDAQ and NYSE listed companies that are overlooked by Wall Street. Investors can choose to receive trading strategies via text message (SMS) or email. To receive free text message alerts text the word ULTIMATE to 555888 from your cell phone. For more information visit

Disclosure: is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit website, for complete risks and disclosures.

Write Your Comment